Delcath Systems (DCTH) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.95% |
| Dec 31, 2025 | 29.46% |
| Sep 30, 2025 | 24.62% |
| Jun 30, 2025 | 23.98% |
| Mar 31, 2025 | 19.35% |
| Dec 31, 2024 | 28.46% |
| Sep 30, 2024 | 21.69% |
| Jun 30, 2024 | -6.88% |
| Mar 31, 2024 | -28.18% |
| Dec 31, 2023 | -34.79% |
| Sep 30, 2023 | -20.43% |
| Jun 30, 2023 | -27.76% |
| Mar 31, 2023 | 7.92% |
| Dec 31, 2022 | -14.50% |
| Sep 30, 2022 | -8.02% |
| Jun 30, 2022 | -6.92% |
| Mar 31, 2022 | -10.80% |
| Dec 31, 2021 | -10.77% |
| Sep 30, 2021 | -6.22% |
| Jun 30, 2021 | -17.65% |
| Mar 31, 2021 | -3.65% |
| Dec 31, 2020 | -3.56% |
| Sep 30, 2020 | -7.99% |
| Jun 30, 2020 | -11.57% |
| Mar 31, 2020 | -3.45% |
| Dec 31, 2019 | -11.44% |
| Sep 30, 2019 | -25.67% |
| Jun 30, 2019 | 4.40% |
| Mar 31, 2019 | 9.20% |
| Dec 31, 2018 | 18.81% |
| Sep 30, 2018 | 13.32% |
| Jun 30, 2018 | 23.13% |
| Mar 31, 2018 | 10.04% |
| Dec 31, 2017 | 16.75% |
| Sep 30, 2017 | 23.52% |
| Jun 30, 2017 | 19.79% |
| Mar 31, 2017 | 23.09% |
| Dec 31, 2016 | 23.23% |
| Sep 30, 2016 | 17.59% |
| Jun 30, 2016 | 16.02% |
| Mar 31, 2016 | 10.70% |
| Dec 31, 2015 | 10.04% |
| Sep 30, 2015 | 11.67% |